Treatment of Postural Hypotension
JNNP 65:285-289, Mathias,C.J.&Kimber,J.R., 1998
Orthostatic Hypotension as a Risk Factor for Symptomatic Occlusive Cerebrovascular Disease
Neurol 39:30-34, Dobkin,B.H., 1989
Clinical Features of Dopamine Agonist Withdrawal Syndrome in a Movement Disorders Clinic
JNNP 84:130-135, Pondal, M.,et al, 2013
A 75-Year-Old Man With Cognitive Impairment and Gait Changes, Lewy Body Disease
Neurol 69:1183-1189, Lippa,C.F.,et al, 2007
Syncope and Falls Due to Timolol Eye Drops
BMJ 332:960-961, Mller,M.E.,et al, 2006
Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease
Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
Serotonin Syndrome
Neurol 45:219-223, Bodner,R.A.,et al, 1995
Neurologic Aspects of Cobalamin Deficiency
Medicine 70:229-245, Healton,E.B.,et al, 1991
Prevention of Falls Among the Elderly
NEJM 320:1055-1059, Tinetti,M.E.&Speechley,M., 1989
The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989
Risk Factors for Falls Among Elderly Persons Living in the Community
NEJM 319:1701-1707, Tinetti,M.E.,et al, 1988
Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974